<?xml version="1.0" encoding="UTF-8"?>
<p id="Par12">Based on the clinical studies in humans, performing short-term exercise (e.g. 45–60 min), and moderate exercise (40–60% 
 <italic>V</italic>O
 <sub>2max</sub>), at least 3 times per week is useful for the immune system [
 <xref ref-type="bibr" rid="CR51">51</xref>]. Moderate-intensity exercise is also associated with increased leukocyte function in humans [
 <xref ref-type="bibr" rid="CR52">52</xref>]. Exercise increases chemotaxis, degranulation, cytotoxic activity, phagocytosis, and oxidative activity of neutrophils and macrophages in rats [
 <xref ref-type="bibr" rid="CR53">53</xref>]. Increased cytolytic activity of NK cells and activating lymphokine-activated killer cells (LAK) during 60 min of moderate-intensity exercise has also been reported by healthy cyclists [
 <xref ref-type="bibr" rid="CR54">54</xref>]. Various studies have shown that regular exercise (resistance or endurance training) increases macrophage phagocytosis, oxidative burst, neutrophil oxidative burst, percentage of TCD4 lymphocytes, and reduces circulating TNF-α and IL-6 [
 <xref ref-type="bibr" rid="CR51">51</xref>]. Therefore, exercise training with positive effects on the immune system can play a therapeutic and preventive effect against COVID-19.
</p>
